WELL Health plans even more acquisitions

Article Excerpt

Growth by acquisition adds risk, but WELL Health aims to cut that risk by buying complementary businesses. As well, the Canadian health-care sector is a government-backed, recession-resilient industry. WELL HEALTH TECHNOLOGIES, $6.25, is a buy. The company (Toronto symbol WELL; TSINetwork Rating: Speculative) (www.well.company; Shares outstanding: 249.9 million; Market cap: $1.6 billion; No dividend paid) completed seven acquisitions in 2024. They include one of the largest physician recruitment firms in Canada, two Canadian Primary Care Clinics, and one provider staffing firm in the U.S. These new assets added $100 million to the company’s annual revenue of about $958 million. WELL is also looking at more acquisitions that would add another $65 million in annual revenues. These new businesses will probably lift WELL’s projected earnings, from $0.24 a share in 2024 to $0.32 in 2025. The stock, which has soared a stellar 60% in the past year, trades at a reasonable 19.5 times that 2025 forecast. WELL Health is a buy for aggressive investors. investors…